These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 21856484)
1. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Shah AM; Mann DL Lancet; 2011 Aug; 378(9792):704-12. PubMed ID: 21856484 [TBL] [Abstract][Full Text] [Related]
2. Structural basis of ventricular remodeling: role of the myocyte. Li F; Wang X; Yi XP; Gerdes AM Curr Heart Fail Rep; 2004; 1(1):5-8. PubMed ID: 16036018 [TBL] [Abstract][Full Text] [Related]
3. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling. Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931 [TBL] [Abstract][Full Text] [Related]
4. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Tarone G; Balligand JL; Bauersachs J; Clerk A; De Windt L; Heymans S; Hilfiker-Kleiner D; Hirsch E; Iaccarino G; Knöll R; Leite-Moreira AF; Lourenço AP; Mayr M; Thum T; Tocchetti CG Eur J Heart Fail; 2014 May; 16(5):494-508. PubMed ID: 24639064 [TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure. Distefano G; Sciacca P Ital J Pediatr; 2012 Sep; 38():41. PubMed ID: 22971785 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure. Tuttolomondo A; Simonetta I; Pinto A Expert Opin Ther Targets; 2016 Nov; 20(11):1287-1300. PubMed ID: 27409295 [TBL] [Abstract][Full Text] [Related]
7. Involvement of NADPH oxidases in cardiac remodelling and heart failure. Sirker A; Zhang M; Murdoch C; Shah AM Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Li L; Chen Y; Doan J; Murray J; Molkentin JD; Liu Q Circulation; 2014 Dec; 130(24):2162-72. PubMed ID: 25278099 [TBL] [Abstract][Full Text] [Related]
9. The dynamic interaction of the extracellular matrix in cardiac remodeling. Goldsmith EC; Borg TK J Card Fail; 2002 Dec; 8(6 Suppl):S314-8. PubMed ID: 12555138 [TBL] [Abstract][Full Text] [Related]
11. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Wollert KC; Drexler H Heart Fail Rev; 2002 Oct; 7(4):317-25. PubMed ID: 12379817 [TBL] [Abstract][Full Text] [Related]
12. The impact of age and frailty on ventricular structure and function in C57BL/6J mice. Feridooni HA; Kane AE; Ayaz O; Boroumandi A; Polidovitch N; Tsushima RG; Rose RA; Howlett SE J Physiol; 2017 Jun; 595(12):3721-3742. PubMed ID: 28502095 [TBL] [Abstract][Full Text] [Related]
13. Cellular events linked to cardiac remodeling in heart failure: targets for pharmacologic intervention. Piano MR; Kim SD; Jarvis C J Cardiovasc Nurs; 2000 Jul; 14(4):1-23; quiz 119-20. PubMed ID: 10902101 [TBL] [Abstract][Full Text] [Related]
14. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Takano H; Hasegawa H; Nagai T; Komuro I Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042 [TBL] [Abstract][Full Text] [Related]
15. Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by chronic volume overload in rats. Ding YF; Brower GL; Zhong Q; Murray D; Holland M; Janicki JS; Zhong J Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):827-35. PubMed ID: 18346170 [TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic targets in chronic heart failure: part II. Roenicke V; Leclair S; Hoffmann A; Becker M; Szado T; Kirsch T; Stoss O; Navé BT; Henkel T Expert Opin Ther Targets; 2003 Feb; 7(1):49-59. PubMed ID: 12556202 [TBL] [Abstract][Full Text] [Related]
17. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload. Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050 [TBL] [Abstract][Full Text] [Related]
18. Post-infarction myocardial remodelling: why does it happen? Francis GS; Chu C Eur Heart J; 1995 Dec; 16 Suppl N():31-6. PubMed ID: 8682059 [TBL] [Abstract][Full Text] [Related]